Nerve Repair and Regeneration Market Overview
Nerve repair and regeneration refer to the regrowth or repair of nervous tissues, cells or cell products. Such mechanisms may include the generation of new neurons, glia, axons, myelin, or synapses. Nerve injuries can be caused by blunt trauma or traction injuries. An increasing incidence of nervous system injuries is the major reason for enhancing the demand for nerve repair and regeneration procedures.
Furthermore, additional factors such as the growing old age population across the globe, technological advancements in nerve repair, developed efficiency of biomaterials in treating nervous system injuries, and rising rate of chronic CNS disorders such as Alzheimer’s and Parkinson’s disease are significantly escalating the demand for nerve repair and regeneration procedures. Eventually, it boosts the growth of the market. According to World Health Organization, Alzheimer’s disease and other forms of dementia are now among the top 10 causes of death worldwide, ranking 3rd in both the Americas and Europe in 2019. Women are disproportionally affected: globally, 65% of deaths from Alzheimer’s and other forms of dementia are women.
On the other side, factors such as lack of awareness among patients and physicians related to nerve repair and regeneration products and techniques and shortage of skilled professionals are expected to hamper the growth of the market in near future.
Nerve Repair and Regeneration Market Segment Overview
According to, Neurostimulation and Neuromodulation Devices, the spinal cord stimulation devices segment holds the largest share of the market. This is mainly due to the high commercial availability of spinal cord products and their several applications. Additionally, based on Surgery, the Stem Cell Therapy segment is the fastest-growing segment in the market. This can be attributed to, the increasing investments by key companies for R&D activities to develop more effective devices. For instance, in May 2016, Boston Scientific Corporation announced the launch of the Precision Montage™ MRI Spinal Cord Stimulator (SCS) System after receiving approval from the U.S. Food and Drug Administration.
Nerve Repair and Regeneration Market Regional Overview
Based on the region, North America is anticipated to dominate the overall market, throughout the forecast period. This is on account of the high incidence of chronic disorders such as Parkinson’s, Alzheimer’s, epilepsy, chronic pain, depression, and others in this region. Similarly, the Asia Pacific and Europe contributing significantly to the growth of the market. Factors such as growing expenditure on healthcare and increasing awareness among the patient population in these regions are expected to boost the Nerve Repair and Regeneration Market development in the forthcoming period.
Nerve Repair and Regeneration Market, Key Players
· Alafair Biosciences Inc.
· Baxter International Inc.
· AxoGen Inc.
· Boston Scientific Corporation
· Integra Lifesciences Holdings Corporation
· Cyberonics Inc.
· Medtronic Inc.
· Stryker Corporation
· St. Jude Medical Inc.
· Abbott Laboratories
· LivaNova, PLC.
· NeuroPace, Inc.
· Soterix Medical, Inc.
· Nevro Corp
· Collagen Matrix, Inc.
Nerve Repair and Regeneration Market Segmentation
Nerve Repair and Regeneration Market, By Product
· Nerve Grafting
· Direct Nerve Repair
· Stem Cell Therapy
Nerve Repair and Regeneration Market, By Region:
Nerve repair and regeneration refer to the regrowth or repair of nervous tissues, cells or cell products. Such mechanisms may include the generation of new neurons, glia, axons, myelin, or synapses. Nerve injuries can be caused by blunt trauma or traction injuries. An increasing incidence of nervous system injuries is the major reason for enhancing the demand for nerve repair and regeneration procedures.
Furthermore, additional factors such as the growing old age population across the globe, technological advancements in nerve repair, developed efficiency of biomaterials in treating nervous system injuries, and rising rate of chronic CNS disorders such as Alzheimer’s and Parkinson’s disease are significantly escalating the demand for nerve repair and regeneration procedures. Eventually, it boosts the growth of the market. According to World Health Organization, Alzheimer’s disease and other forms of dementia are now among the top 10 causes of death worldwide, ranking 3rd in both the Americas and Europe in 2019. Women are disproportionally affected: globally, 65% of deaths from Alzheimer’s and other forms of dementia are women.
On the other side, factors such as lack of awareness among patients and physicians related to nerve repair and regeneration products and techniques and shortage of skilled professionals are expected to hamper the growth of the market in near future.
Nerve Repair and Regeneration Market Segment Overview
According to, Neurostimulation and Neuromodulation Devices, the spinal cord stimulation devices segment holds the largest share of the market. This is mainly due to the high commercial availability of spinal cord products and their several applications. Additionally, based on Surgery, the Stem Cell Therapy segment is the fastest-growing segment in the market. This can be attributed to, the increasing investments by key companies for R&D activities to develop more effective devices. For instance, in May 2016, Boston Scientific Corporation announced the launch of the Precision Montage™ MRI Spinal Cord Stimulator (SCS) System after receiving approval from the U.S. Food and Drug Administration.
Nerve Repair and Regeneration Market Regional Overview
Based on the region, North America is anticipated to dominate the overall market, throughout the forecast period. This is on account of the high incidence of chronic disorders such as Parkinson’s, Alzheimer’s, epilepsy, chronic pain, depression, and others in this region. Similarly, the Asia Pacific and Europe contributing significantly to the growth of the market. Factors such as growing expenditure on healthcare and increasing awareness among the patient population in these regions are expected to boost the Nerve Repair and Regeneration Market development in the forthcoming period.
Nerve Repair and Regeneration Market, Key Players
· Alafair Biosciences Inc.
· Baxter International Inc.
· AxoGen Inc.
· Boston Scientific Corporation
· Integra Lifesciences Holdings Corporation
· Cyberonics Inc.
· Medtronic Inc.
· Stryker Corporation
· St. Jude Medical Inc.
· Abbott Laboratories
· LivaNova, PLC.
· NeuroPace, Inc.
· Soterix Medical, Inc.
· Nevro Corp
· Collagen Matrix, Inc.
Nerve Repair and Regeneration Market Segmentation
Nerve Repair and Regeneration Market, By Product
- Biomaterial
- Neurostimulation and Neuromodulation Devices
- External stimulation devices
- Transcutaneous Electrical Nerve Stimulation (TENS)
- Transcranial Magnetic Stimulation (TMS)
- Internal stimulation devices
- Gastric Electrical Stimulation (GES)
- Vagus Nerve Stimulation (VNS)
- Spinal Cord Stimulation (SGS)
- Sacral Nerve Stimulation (SNS)
- Deep Brain Stimulation (DBS)
· Nerve Grafting
· Direct Nerve Repair
· Stem Cell Therapy
Nerve Repair and Regeneration Market, By Region:
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Nerve Repair and Regeneration Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Product
- 5.2.1. Biomaterial
- 5.2.2. Neurostimulation and Neuromodulation Devices
- 5.2.2.1. External stimulation devices
- 5.2.2.1.1. Transcutaneous Electrical Nerve Stimulation (TENS)
- 5.2.2.1.2. Transcranial Magnetic Stimulation (TMS)
- 5.2.2.2. Internal stimulation devices
- 5.2.2.2.1. Gastric Electrical Stimulation (GES)
- 5.2.2.2.2. Vagus Nerve Stimulation (VNS)
- 5.2.2.2.3. Spinal Cord Stimulation (SGS)
- 5.2.2.2.4. Sacral Nerve Stimulation (SNS)
- 5.2.2.2.5. Deep Brain Stimulation (DBS)
- 5.3. Market Analysis, Insights and Forecast – By Surgery
- 5.3.1. Nerve Grafting
- 5.3.2. Direct Nerve Repair
- 5.3.3. Stem Cell Therapy
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Latin America
- 5.4.3. Europe
- 5.4.4. Asia Pacific
- 5.4.5. Middle East and Africa
- 5.2.2.1. External stimulation devices
6. North America Nerve Repair and Regeneration Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Product
- 6.2.1. Biomaterial
- 6.2.2. Neurostimulation and Neuromodulation Devices
- 6.2.2.1. External stimulation devices
- 6.2.2.1.1. Transcutaneous Electrical Nerve Stimulation (TENS)
- 6.2.2.1.2. Transcranial Magnetic Stimulation (TMS)
- 6.2.2.2. Internal stimulation devices
- 6.2.2.2.1. Gastric Electrical Stimulation (GES)
- 6.2.2.2.2. Vagus Nerve Stimulation (VNS)
- 6.2.2.2.3. Spinal Cord Stimulation (SGS)
- 6.2.2.2.4. Sacral Nerve Stimulation (SNS)
- 6.2.2.2.5. Deep Brain Stimulation (DBS)
- 6.3. Market Analysis, Insights and Forecast – By Surgery
- 6.3.1. Nerve Grafting
- 6.3.2. Direct Nerve Repair
- 6.3.3. Stem Cell Therapy
- 6.4. Market Analysis, Insights and Forecast – By Country
- 6.4.1. U.S.
- 6.4.2. Canada
- 6.2.2.1. External stimulation devices
7. Latin America Nerve Repair and Regeneration Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Product
- 7.2.1. Biomaterial
- 7.2.2. Neurostimulation and Neuromodulation Devices
- 7.2.2.1. External stimulation devices
- 7.2.2.1.1. Transcutaneous Electrical Nerve Stimulation (TENS)
- 7.2.2.1.2. Transcranial Magnetic Stimulation (TMS)
- 7.2.2.2. Internal stimulation devices
- 7.2.2.2.1. Gastric Electrical Stimulation (GES)
- 7.2.2.2.2. Vagus Nerve Stimulation (VNS)
- 7.2.2.2.3. Spinal Cord Stimulation (SGS)
- 7.2.2.2.4. Sacral Nerve Stimulation (SNS)
- 7.2.2.2.5. Deep Brain Stimulation (DBS)
- 7.3. Market Analysis, Insights and Forecast – By Surgery
- 7.3.1. Nerve Grafting
- 7.3.2. Direct Nerve Repair
- 7.3.3. Stem Cell Therapy
- 7.4. Market Analysis, Insights and Forecast – By Country
- 7.4.1. Brazil
- 7.4.2. Mexico
- 7.4.3. Rest of Latin America
- 7.2.2.1. External stimulation devices
8. Europe Nerve Repair and Regeneration Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Product
- 8.2.1. Biomaterial
- 8.2.2. Neurostimulation and Neuromodulation Devices
- 8.2.2.1. External stimulation devices
- 8.2.2.1.1. Transcutaneous Electrical Nerve Stimulation (TENS)
- 8.2.2.1.2. Transcranial Magnetic Stimulation (TMS)
- 8.2.2.2. Internal stimulation devices
- 8.2.2.2.1. Gastric Electrical Stimulation (GES)
- 8.2.2.2.2. Vagus Nerve Stimulation (VNS)
- 8.2.2.2.3. Spinal Cord Stimulation (SGS)
- 8.2.2.2.4. Sacral Nerve Stimulation (SNS)
- 8.2.2.2.5. Deep Brain Stimulation (DBS)
- 8.3. Market Analysis, Insights and Forecast – By Surgery
- 8.3.1. Nerve Grafting
- 8.3.2. Direct Nerve Repair
- 8.3.3. Stem Cell Therapy
- 8.4. Market Analysis, Insights and Forecast – By Country
- 8.4.1. UK
- 8.4.2. Germany
- 8.4.3. France
- 8.4.4. Italy
- 8.4.5. Spain
- 8.4.6. Russia
- 8.4.7. Rest of Europe
- 8.2.2.1. External stimulation devices
9. Asia Pacific Nerve Repair and Regeneration Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Product
- 9.2.1. Biomaterial
- 9.2.2. Neurostimulation and Neuromodulation Devices
- 9.2.2.1. External stimulation devices
- 9.2.2.1.1. Transcutaneous Electrical Nerve Stimulation (TENS)
- 9.2.2.1.2. Transcranial Magnetic Stimulation (TMS)
- 9.2.2.2. Internal stimulation devices
- 9.2.2.2.1. Gastric Electrical Stimulation (GES)
- 9.2.2.2.2. Vagus Nerve Stimulation (VNS)
- 9.2.2.2.3. Spinal Cord Stimulation (SGS)
- 9.2.2.2.4. Sacral Nerve Stimulation (SNS)
- 9.2.2.2.5. Deep Brain Stimulation (DBS)
- 9.3. Market Analysis, Insights and Forecast – By Surgery
- 9.3.1. Nerve Grafting
- 9.3.2. Direct Nerve Repair
- 9.3.3. Stem Cell Therapy
- 9.4. Market Analysis, Insights and Forecast – By Country
- 9.4.1. China
- 9.4.2. India
- 9.4.3. Japan
- 9.4.4. Australia
- 9.4.5. South East Asia
- 9.4.6. Rest of Asia Pacific
- 9.2.2.1. External stimulation devices
10. Middle East & Africa Nerve Repair and Regeneration Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 10.1. Key Findings / Summary
- 10.2. Market Analysis, Insights and Forecast – By Product
- 10.2.1. Biomaterial
- 10.2.2. Neurostimulation and Neuromodulation Devices
- 10.2.2.1. External stimulation devices
- 10.2.2.1.1. Transcutaneous Electrical Nerve Stimulation (TENS)
- 10.2.2.1.2. Transcranial Magnetic Stimulation (TMS)
- 10.2.2.2. Internal stimulation devices
- 10.2.2.2.1. Gastric Electrical Stimulation (GES)
- 10.2.2.2.2. Vagus Nerve Stimulation (VNS)
- 10.2.2.2.3. Spinal Cord Stimulation (SGS)
- 10.2.2.2.4. Sacral Nerve Stimulation (SNS)
- 10.2.2.2.5. Deep Brain Stimulation (DBS)
- 10.3. Market Analysis, Insights and Forecast – By Surgery
- 10.3.1. Nerve Grafting
- 10.3.2. Direct Nerve Repair
- 10.3.3. Stem Cell Therapy
- 10.4. Market Analysis, Insights and Forecast – By Country
- 10.4.1. GCC
- 10.4.2. South Africa
- 10.4.3. Rest of Middle East & Africa
- 10.2.2.1. External stimulation devices
11. Competitive Analysis
- 11.1. Company Market Share Analysis, 2018
- 11.2. Key Industry Developments
- 11.3. Company Profile
- 11.4. Alafair Biosciences Inc.
- 11.4.1. Business Overview
- 11.4.2. Segment 1 & Service Offering
- 11.4.3. Overall Revenue
- 11.4.4. Geographic Presence
- 11.4.5. Recent Development
- 11.5. Baxter International Inc.
- 11.6. AxoGen Inc.
- 11.7. Boston Scientific Corporation
- 11.8. Integra Lifesciences Holdings Corporation
- 11.9. Cyberonics Inc.
- 11.10. Medtronic Inc.
- 11.11. Stryker Corporation
- 11.12. St. Jude Medical Inc.
- 11.13. Abbott Laboratories
- 11.14. LivaNova, PLC.
- 11.15. NeuroPace, Inc.
- 11.16. Soterix Medical, Inc.
- 11.17. Nevro Corp
Research Process
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
